Integra LifeSciences

ISIN US4579852082

 | 

WKN 897013

Marktkapitalisatie (in EUR)
643 m
Land
United States
Sector
Healthcare
Dividendrendement
0.00%
 

Overzicht

Beschrijving

Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Toon meer Toon minder
Healthcare Healthcare Equipment Other Medical Devices United States

Financiële kerngegevens

Kerncijfers

Marktkapitalisatie, EUR 643 m
WPA, EUR -5.97
KBV 0.7
K/W 63.6
Dividendrendement 0.00%

Winst- en verliesrekening (2025)

Omzet, EUR 1,450 m
Netto-inkomen, EUR -458 m
Winstmarge -31.58%

In welke ETF zit Integra LifeSciences?

Er zijn 1 ETF's die Integra LifeSciences bevatten.
ETF Weging Investeringsfocus Fondsgrootte (in m EUR)
iShares S&P SmallCap 600 UCITS ETF 0,05%
Aandelen
Verenigde Staten
Small Cap
2.284
— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.

Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing). Er is geen garantie voor de volledigheid, juistheid en correctheid van de getoonde informatie.